Jeong SI, Ban MS, Hwang JG, Park MK, et al. The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes Obes Metab 2024 Apr 15. doi: 10.1111/dom.15573.
PMID: 38618974